Because the uncoupling of eNOS is a pathogenesis of essential hypertension, any therapeutic target that is able to restore eNOS coupling activity in blood vessels can be a part of the treatment protocol for hypertensive patients. This evidence concerns the gene NOS3 and essential hypertension.